Topical tacalcitol and MEL308 nm:a synergistic combination for the treatment of vitiligo

TANG Lu-yan,FU Wen-wen,XIANG Lei-hong,JIN Yi,ZHENG Zhi-zhong
DOI: https://doi.org/10.3760/j.issn:0412-4030.2006.06.003
2006-01-01
Chinese Journal of Dermatology
Abstract:Objective To study the efficacy and safety of tacalcitol combined with monochromatic excimer light (MEL) 308 nm vs MEL 308 nm monotherapy in treating vitiligo.Methods Thirty-eight pa- tients with vitiligo were enrolled in the single-blind clinical trial,using plabebo-treated lesions in the same patient as controls.Contralateral or nearby lesions were randomly selected to be treated by either tacalcitol or placebo.All lesions were treated weekly with MEL 308 nm,for a total of 12 sessions.Patients were ex- amined at monthly intervals.The mean number of sessions and the cumulative dosage for initial and excel- lent repigrnentation were calculated.Results Thirty-five patients were evaluated.The mean±SEM cumu- lative dose and number of MEL exposures for initial repigmentation,respectively,were 4.27±3.59 J/cm~2 and 4.89±3.16 on tacalcitol-treated site,5.36±4.12 J/cm~2 and 5.69±3.29 on placebo-treated site,re- spectively (both P<0.05).For excellent repigrnentation,the cumulative dose and number of exposures were 7.72±5.64 J/cm~2 and 7.79±4.70 respectively on tacalcitol-treated site,and 8.18±4.87 J/cm~2 and 8.4±3.92 respectively on placebo-treated site (both P>0.05).Treatment with tacalcitol resulted in a sig- nificantly higher percentage (71.4% vs 54.3%) of repigmentation than that with placebo.Conclusions Our results show that MEL 308 nm is safe and effective for the treatment of vitiligo.Additionally,concur- rent topical tacalcitol potentiates the efficacy of MEL 308 nm in the treatment of vitiligo;this combination achieves more rapid pigmentation with a lower total MEL dosage.
What problem does this paper attempt to address?